Imaging liver nodules in tyrosinemia type-1: A retrospective review of 16 cases in a tertiary pediatric hospital

Eur J Radiol. 2019 Jul:116:41-46. doi: 10.1016/j.ejrad.2019.04.016. Epub 2019 Apr 23.

Abstract

Objective: To describe the liver imaging findings of Hereditary tyrosinemia type-1 (HT1) patients.

Materials and methods: We report 16 patients (8 Female and 8 Male) with HT-1. Their demographic features, imaging findings and alpha feto protein (AFP) levels were recorded. Imaging features on CT and MR were evaluated for the following characteristics: contour of the liver and liver nodules. Liver nodules were categorized as; regenerative, dysplastic, fatty and malignant nodules (HCC).

Results: Thirteen (81%) patients had multiple liver nodules (>20) on imaging studies. Five patients (31%) had regenerative nodules, six (38%) had dysplastic nodules and ten (63%) had fatty nodules. Dysplastic nodules were encountered in two patients with HCC and in four patients without a tumor. Four patients (25%) had HCC nodule on imaging studies. Those four patients had biopsy and all of them had HCC nodule on histopathology. In the follow-up period, in one patient fatty nodules had increased in size, in one patient regenerative nodules had disappeared and in one patient dysplastic nodules had disappeared.

Conclusions: Multiple fatty nodules can be seen in HT1 patients and in some patients, the regenerative and dysplastic nodules can disappear during the follow-up period.

Keywords: Liver; Magnetic resonance imaging; Tyrosinemia type 1.

MeSH terms

  • Carcinoma, Hepatocellular / complications*
  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / pathology
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Neoplasms / complications*
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / pathology
  • Magnetic Resonance Imaging / methods*
  • Male
  • Retrospective Studies
  • Tertiary Care Centers
  • Tyrosinemias / complications*